ACEi, ARB Use Linked to Lower Risk for Kidney Failure With Replacement Therapy
By Elana Gotkine HealthDay Reporter
MONDAY, July 8, 2024 -- For individuals with advanced chronic kidney disease (CKD), angiotensin-converting enzyme inhibitor (ACEi) or angiotensin-receptor blocker (ARB) treatment is associated with a reduced risk for kidney failure with replacement therapy (KFRT) but not death, according to a study published online July 2 in the Annals of Internal Medicine.
Elaine Ku, M.D., from the University of California in San Francisco, and colleagues examined the association of ACEi or ARB treatment initiation with rates of KFRT and death using data from completed randomized controlled trials from 1946 through Dec. 31, 2023.
Data were included for 1,739 participants from 18 trials, and of these patients, 35.9 and 7.6 percent developed KFRT and died, respectively, during a median follow-up of 34 months. The researchers found that the risk for KFRT was lower with ACEi or ARB treatment initiation (adjusted hazard ratio, 0.66; 95 percent confidence interval, 0.55 to 0.79), but the risk for death was not significantly lower (adjusted hazard ratio, 0.86; 95 percent confidence interval, 0.58 to 1.28). No significant interactions were seen between ACEi or ARB treatment and age, estimated glomerular filtration rate, albuminuria, or diabetes.
"Initiation of ACEi or ARB therapy protects against KFRT, but not against death, in people with advanced CKD," the authors write. "Even in an era where other agents, such as sodium-glucose cotransporter-2 inhibitors, are available, significant benefit can be derived from the initiation of ACEi or ARB treatment in patients with low glomerular filtration rate."
Several authors disclosed ties to the pharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted July 2024
Read this next
Kidney Transplant Rate Increasing, but Efficiency of Allocation System Low
WEDNESDAY, May 7, 2025 -- The number of kidney transplants performed annually in the United States has increased steadily, but with decreasing allocation efficiency, according to...
Higher Temperatures Tied to Greater Risk for Mortality in People Undergoing Dialysis
WEDNESDAY, April 23, 2025 -- Moderately elevated ambient temperature is associated with increased mortality in patients undergoing dialysis, according to a study published in the...
Proinflammatory Diet Tied to Higher Risk for Chronic Kidney Disease
WEDNESDAY, April 23, 2025 -- Individuals who eat a proinflammatory diet have a higher likelihood of chronic kidney disease, according to a review published online April 16 in...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.